Prevent Blindness America advocates funding eye-health programs

Article

Prevent Blindness America is leading the effort to secure federal funding for programs that prevent blindness and preserve sight.

Key Points

Chicago-Prevent Blindness America (PBA) is leading the effort to secure federal funding for programs that prevent blindness and preserve sight.

PBA provided written testimony to the House and Senate Appropriations Labor, Health and Human Services, Education, and Related Agencies subcommittees to urge Congress to support increased funding for federal vision health and eye programs for fiscal year 2010. Specifically, PBA requested $4.5 million to the federal Centers for Disease Control and Prevention's Vision Health Initiative, $736 million for the National Eye Institute, and $32.4 billion for the National Institutes of Health to support biomedical research.

More than 80 million Americans are at risk for a potentially blinding eye disease, including diabetic retinopathy, glaucoma, cataract, and age-related macular degeneration, according to the PBA. A recent PBA study estimated the annual costs associated with adult vision problems in the United States at $51.4 billion.

"We understand the crucial impact that vision research has on saving sight and have made it part of our mission to fund projects that help to protect our eyes and maintain healthy vision," said Hugh R. Parry, president and chief executive officer of PBA.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.